StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Sona gets a kick in the teeth. Down 68%.

<< Previous

Bullboard Posts

Next >>

Comment by molotov420on Jun 11, 2021 12:27pm

142 Views

Post# 33372713

RE:RE:Sona gets a kick in the teeth. Down 68%.

They reported almost 500K for 2020, however the cancer revs seem to have tried up again in Q1. I asked both IR and Tripp about the increase in 2020 and go nothing...SAD. Starting to think it was a typo meant to read $500 not 500K.

<< Previous

Bullboard Posts

Next >>

New glaucoma treatment studied in a $3.4 billion market